Concanavalin A (ConA)
Derangements of liver tissue bioenergetics in Concanavalin A-induced hepatitis
13
Protective effect of galangin in Concanavalin A- induced hepatitis in mice
10
Human liver stem cells attenuate concanavalin A-induced acute liver injury by modulating myeloid-derived suppressor cells and CD4+ T cells in mice
11
Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis
10
Concanavalin A inhibits tissue factor coagulant activity
6
Concanavalin A induced liver injury triggers hepatocyte proliferation
11
Studies of Two Subpopulations of Human Lymphocytes Differing in Responsiveness to Concanavalin A
11
Fractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the molecule
11
Anti-hepatitis, antioxidant activities and bioactive compounds of Dracocephalum heterophyllum extracts
11
Evidence for an Adenovirus Type 2-Coded Early Glycoprotein
10
Changes in the immune system in experimental acanthamoebiasis in immunocompetent and immunosuppressed hosts
14
ConA-based glucose sensing using the long-lifetime azadioxatriangulenium fluorophore
7
Inactivation of Herpes Simplex Virus by Concanavalin A
7
Leishmania infantum specific IFN γ production in stimulated blood from cats living in areas where canine leishmaniosis is endemic
9
Characterization of an African trypanosome mutant refractory to lectin-induced death.
6
Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice
12
Lectin of Concanavalin A as an anti-hepatoma therapeutic agent
12
Quantitative Binding of 125I-Concanavalin A to Normal and Transformed Cells
6
Overcoming the aggregation problem : a new type of fluorescent ligand for ConA-based glucose sensing
15
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2
12